Novartis AG Deferred Tax Assets Recognised As Of Acquisition Date
Novartis AG (NVSEF) had Deferred Tax Assets Recognised As Of Acquisition Date of $465.00 million as of 2024-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Notes › Income Taxes
ifrs-full:DeferredTaxAssetsRecognisedAsOfAcquisitionDate · last filed 2026-02-04
- 2024-12-31: Deferred Tax Assets Recognised As Of Acquisition Date $465.00M.
- 2024-06-30: Deferred Tax Assets Recognised As Of Acquisition Date $315.00M.
- 2023-12-31: Deferred Tax Assets Recognised As Of Acquisition Date $34.00M.
- 2022-12-31: Deferred Tax Assets Recognised As Of Acquisition Date $56.00M.
| Period end | Deferred Tax Assets Recognised As Of Acquisition Date |
|---|---|
| 2024-12-31 | $465.00M 20-F · filed 2026-02-04 |
| 2024-06-30 | $315.00M 6-K · filed 2024-07-18 |
| 2023-12-31 | $34.00M 20-F · filed 2025-01-31 |
| 2022-12-31 | $56.00M 20-F · filed 2024-01-31 |
| 2022-06-30 | $53.00M 6-K · filed 2023-07-18 |
| 2021-12-31 | $28.00M 20-F · filed 2024-01-31 |
| 2021-06-30 | $12.00M 6-K · filed 2022-07-19 |
| 2020-12-31 | $476.00M 20-F/A · filed 2023-05-15 |
| 2020-06-30 | $470.00M 6-K · filed 2021-07-21 |
| 2019-12-31 | $60.00M 20-F · filed 2022-02-02 |
| 2019-06-30 | $20.00M 6-K · filed 2020-07-21 |
| 2018-12-31 | $381.00M 20-F · filed 2021-01-26 |
| 2017-12-31 | $8.00M 20-F · filed 2020-01-29 |
| 2016-12-31 | $39.00M 20-F · filed 2019-01-30 |
| 2015-12-31 | $555.00M 6-K · filed 2018-01-24 |